Nutrition
Volume 26, Issue 4 , Pages 375-381 , April 2010

The safety of oral use of l-glutamine in middle-aged and elderly individuals

  • Siulmara Cristina Galera, M.D., Ph.D., M.Sc.

      Affiliations

    • Department of Surgery, Federal University of Ceará, Fortaleza, Ceará, Brazil
    • Corresponding Author InformationCorresponding author. Tel.: +55-85-3366-9063; fax: +55-85-3366-8064.
    • ,
  • FranciscoVagnaldo Fechine, M.D., Ph.D.

      Affiliations

    • Department of Physiology and Pharmacology, Federal University of Ceará, Fortaleza, Ceará, Brazil
    • ,
  • Maria Jânia Teixeira, Ph.D.

      Affiliations

    • Department of Pathology and Forensic Medicine, Federal University of Ceará, Fortaleza, Ceará, Brazil
    • ,
  • Zirlane Castelo Branco Coelho, M.Sc.

      Affiliations

    • Department of Clinical and Toxicologic Laboratory, Federal University of Ceará, Fortaleza, Ceará, Brazil
    • ,
  • Raquel Cavalcante de Vasconcelos

      Affiliations

    • School of Medicine, Federal University of Ceará, Fortaleza, Ceará, Brazil
    • ,
  • Paulo Roberto Leitão de Vasconcelos, M.D., D.Phil.

      Affiliations

    • Department of Surgery, Federal University of Ceará, Fortaleza, Ceará, Brazil

Received 8 December 2008 ,Accepted 16 May 2009.

References 

  1. Curi R, Lagranha CJ, Doi SQ, Sellitti DF, Procopio J, Pithon-Curi TC, et al. Molecular mechanisms of glutamine action. J Cell Physiol. 2005;204:392–401
  2. Matilla B, Ortíz J, González P, García-Díez F, Jorquera F, Culebras JM, et al. Effects of parenteral nutrition supplemented with glutamine or glutamine dipeptides on liver antioxidant and detoxication systems in rats. Nutrition. 2000;16:125–128
  3. Bonet A, Grau T. La glutamina, un aminoácido casi indispensable en el enfermo crítico. Med Intensiva. 2007;31:402–406
  4. Sacks GS. Glutamine supplementation in catabolic patients. Ann Pharmacother. 1999;33:348–354
  5. Tapiero H, Mathé G, Couvreur P, Tew KD. Glutamine and glutamate. Biomed Pharmacother. 2002;56:446–457
  6. Grimble RF. Immunonutrition. Curr Opin Gastroenterol. 2005;21:216–222
  7. Valencia E, Marin A, Hardy G. Glutathione—nutritional and pharmacological viewpoints: part II. Nutrition. 2001;17:485–486
  8. Castell LM, Newsholme EA. The effects of oral glutamine supplementation on athletes after prolonged, exhaustive exercise. Nutrition. 1997;13:738–742
  9. Valencia E, Marin A, Hardy G. Impact of oral L-glutamine on glutathione, glutamine, and glutamate blood levels in volunteers. Nutrition. 2002;26:367–370
  10. Cynober L. Glutamine as an activator of immune cells: how does it work?. Nutrition. 1997;134:688–689
  11. Gao ZY, Li G, Najafi H, Wolf BA, Matschinsky FM. Glucose regulation of glutaminolysis and its role in insulin secretion. Diabetes. 1999;48:1535–1542
  12. Conejero R, Bonet A, Grau T, Esteban A, Mesejo A, Montejo JC, et al. Effect of a glutamine-enriched enteral diet on intestinal permeability and infectious morbidity at 28 days in critically ill patients with systemic inflammatory response syndrome: a randomized, single-blind, prospective, multicenter study. Nutrition. 2002;18:716–721
  13. Déchelotte P, Hasselmann M, Cynober L, Allaouchiche B, Coëffier M, Hecketsweiler B, et al. L-alanyl-L-glutamine dipeptide-supplemented total parenteral nutrition reduces infectious complications and glucose intolerance in critically ill patients: the French controlled, randomized, double-blind, multicenter study. Crit Care Med. 2006;34:598–604
  14. García-de-Lorenzo A, Zarazaga A, García-Luna PP, Gonzalez-Huix F, López-Martinez J, Miján A, et al. Clinical evidence for enteral nutritional support with glutamine: a systematic review. Nutrition. 2003;19:805–811
  15. Fürst P, Pogan K, Stehle P. Glutamine dipeptides in clinical nutrition. Nutrition. 1997;13:731–737
  16. Rogero MM, Tirapegui J, Pedrosa RG, Castro IA, Pires IS, Chem B. Effect of alanyl-glutamine supplementation on plasma and tissue glutamine concentrations in rats submitted to exhaustive exercise. Nutrition. 2006;22:564–571
  17. Garlick PJ. Assessment of the safety of glutamine and other amino acids. J Nutr. 2001;131:2556S–61
  18. Ziegler TR, Benfell K, Smith RJ, Young LS, Brown E, Ferrari-Baliviera E, et al. Safety and metabolic effects of L-glutamine administration in humans. JPEN. 1990;14:137S–46
  19. Papaléo Netto M. O estudo da velhice: histórico, definição do campo e termos básicos. In:  Freitas EV,  Py L,  Cançado FAX,  Doll J,  Gorzoni ML editor. Tratado de geriatria e gerontologia. 2nd ed. Rio de Janeiro: Guanabara Koogan; 2006;p. 2–12
  20. Wieman HM. Avoiding common pitfalls of geriatric prescribing. Geriatrics. 1986;41:81–89
  21. Olagnero G, Bendersky S, Genevois C, Granzella L, Montonati ML. Alimentos funcionales: fibra, prebióticos, probióticos y simbióticos. Diaeta. 2007;25:20–33
  22. Olagnero G, Genevois C, Irei V, Marcenado J, Bendersky S. Alimentos funcionales: conceptos, definiciones y marco legal global. Diaeta. 2007;25:31–39
  23. Ligthart GJ, Corberand JX, Fournier C, Galanaud P, Hijmans W, Kennes B, et al. Admission criteria for immunogerontological studies in man: the SENIEUR protocol. Mech Ageing Dev. 1984;28:47–55
  24. Henry JB. Diagnósticos clínicos e tratamento por métodos laboratoriais. 2nd ed.. São Paulo: Manole; 1999;
  25. Burtis CA, Ashwood ER. Tietz textbook of clinical chemistry. 2nd ed.. Philadelphia: WB Saunders; 1994;
  26. Trinder P. Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann Clin Biochem. 1969;6:24–27
  27. Gella FJ, Olivella T, Cruz Pastor M, Arenas J, Moreno R, Durban R, et al. A simple procedure for routine determination of aspartate aminotransferase and alanine aminotransferase with pyridoxal phosphate. Clin Chim Acta. 1995;153:241–247
  28. Tietz NW. Clinical guide on clinical laboratory tests. 4th ed.. Washington, DC: AACC Press; 1991;
  29. Heyland DK, Dhaliwalm R, Day A, Drover J, Cote H, Wischmeyer P. Optimizing the dose of glutamine dipeptides and antioxidants in critically ill patients: a phase I dose-finding study. JPEN. 2007;31:109–118
  30. Tietz NW, Rinker D, Shaw LM. IFCC methods for the measurement of catalytic concentration of enzymes. Part 5: IFCC methods for alkaline phosphatase. J Clin Chem Clin Biochem. 1983;21:731–748
  31. Van Anken HC, Schiphorst ME. A kinetic determination of ammonia in plasma. Clin Chim Acta. 1974;56:151–157
  32. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31–41
  33. International Physical Activity Questionnaire. Guidelines for data processing and analysis of the International Physical Activity Questionnaire (IPAQ)—short and longs forms. Revised 2002. Available at: http://www.ipaq.ki.se/downloads.htm. Accessed May 29, 2009.
  34. Baretta E, Peres KG. Nível de atividade física e fatores associados em adultos no Município de Joaçaba, Santa Catarina. Brazil: Cad Saude Publica; 2007;23:1595–602
  35. Novak F, Heyland DK, Avenell A, Drover JW, Su X. Glutamine supplementation in serious Illness: A systematic review of the evidence. Crit Care Med. 2002;30:2022–2029
  36. Heyland DK, Dhaliwalm R, Day AG, Muscedere J, Drover J, Sucher U, et al. Reducing Deaths due to Oxidative Stress (The REDOXS© Study): rationale and study design for a randomized trial of glutamine and antioxidant supplementation in critically-ill patients. Proc Nutr Soc. 2006;65:250–263
  37. Garlick PJ. The nature of human hazards associated with excessive intake of amino acids. J Nutr. 2004;134:1633S–9
  38. Roth E, Ochler R, Manhart N, Exner R, Wessner B, Strasser E, et al. Regulative potential of glutamine—relation to glutathione metabolism. Nutrition. 2002;18:217–221
  39. Roth E. Immune cell modulation by amino acids. Clin Nutr. 2007;26:535–544
  40. Vestal RE. Aging and determinants of hepatic drug clearance. Hepatology. 1989;9:331–334
  41. Wyne HA, Cope LH, Mutch E, Rawlins MD, Woodhouse KW, James OF. The effect of age upon liver volume and apparent liver blood flow in healthy man. Hepatology. 1989;9:297–301
  42. Dudrick PS, Souba WW. Amino acids in surgical nutrition. Principles and practice. Surg Clin North Amer. 1991;71:459–475
  43. Hornsby-Lewis L, Shike M, Brown P, Klang M, Pearlstone D, Brennam MF. L-glutamine supplementation in home total parenteral nutrition patients: stability, safety, and effects on intestinal absorption. JPEN. 1994;18:268–273
  44. Lochs H, Hübl W. Metabolic basis for selecting glutamine-containing substrates for parenteral nutrition. JPEN. 1990;14:114S–7
  45. Butterworth RF. Pathophysiology of hepatic encephalopathy: a new look at ammonia. Metab Brain Dis. 2002;17:221–227
  46. Felipo V, Butterworth RF. Neurobiology of ammonia. Prog Neurobiol. 2002;67:259–279
  47. Berg UB. Differences in decline in GFR with age between males and females. References data on clearance of inulin and PAH in potential kidney donors. Nephrol Dial Transplant. 2006;21:577–582
  48. Davies DF, Shok NW. Age changes in glomerular filtration rate, effective renal plasma flow and tubular excretory capacity in adult males. J Clin Invest. 1950;29:449–507
  49. Beck LH. The aging kidney. Defending a delicate balance of fluid and electrolytes. Geriatrics. 2000;55:26–32
  50. Silva FG. The aging kidney: a review—part I. Int Urol Nephrol. 2005;37:185–205
  51. Lemos VM. Considerações sobre medicamentos e o rim no idoso. In:  Carvalho FJW editors. Nefrologia em geriatria. Rio de Janeiro: Rubio; 2008;p. 40–53
  52. Coffman TM. Renal failure caused by therapeutic agents. In:  Greenberg A editors. Primer on kidney diseases. San Diego: Academic Press; 2001;p. 251–257
  53. Raveh D, Kopyt M, Hite Y, Rudensky B, Sonnenblick M, Yinnon AM. Risk factors for nephrotoxicity in elderly patients receiving once-daily aminoglycosides. QJM. 2002;95:291–297
  54. Werneck de Carvalho FJ. Nefroproteção e envelhecimento. In:  Carvalho FJW editors. Nefrologia em geriatria. Rio de Janeiro: Rubio; 2008;p. 29–39
  55. Cirillo M, Anastasio P, De Santo NG. Relationship of gender, age, and body mass index to errors in predicted kidney function. Nephrol Dial Transplant. 2005;20:1791–1798
  56. Consonello A, Pedone C, Corica F, Mussi C, Carboni P, Incalzi RA, et al. Concealed renal insufficiency and adverse drug reactions in elderly hospitalized patients. Arch Intern Med. 2005;165:790–795

 The present study was supported by a grant from Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Ministério de Ciência e Tecnologia, process no. 505304/04, and by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Ministério da Educação, Brazil.

PII: S0899-9007(09)00231-7

doi: 10.1016/j.nut.2009.05.013

Nutrition
Volume 26, Issue 4 , Pages 375-381 , April 2010

Article Tools

* Image Usage & Resolution